Bristol-Myers signs development deal with Alder

Bristol-Myers Squibb Co. and Alder Biopharmaceuticals Inc. said Tuesday they signed a collaboration deal potentially worth $1 billion, with a key focus on a rheumatoid arthritis treatment. (AP, 7:11 a.m.)

Bill Clinton meets with Senate Dems on health care

Former President Bill Clinton knows just how high the political stakes are in the fight to overhaul America's health care system. (AP, 7:32 a.m.)

Status of Pfizer and Wyeth research facilities

Pfizer Inc. , which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites: Former Wyeth sites staying open/Types of future research: (AP, 11/9/09)

Acadia 3Q loss narrows on revenue boost

Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners. (AP, 11/9/09)

Utah's Matheson may get Dem rival over health vote

A Democratic state lawmaker said Monday he may run against U.S. Rep. Jim Matheson because of his vote against health care legislation. (AP, 11/9/09)